Drug application
POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE (POTASSIUM PHOSPHATE, DIBASIC, POTASSIUM PHOSPHATE, MONOBASIC)
Drugs@FDA NDA 218343 · AMNEAL
Key facts
| Drug name | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE |
|---|---|
| Active ingredients | POTASSIUM PHOSPHATE, DIBASIC, POTASSIUM PHOSPHATE, MONOBASIC |
| Application type | NDA |
| Application number | 218343 |
| Company | AMNEAL |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | 1.18GM/250ML (4.72MG/ML);1.12GM/250ML (4.48MG/ML) |
| Marketing status | Prescription |
| Reference listed drug | Yes |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Jul 26, 2024 |
At a glance
- 1–9 Submissions
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: